home / stock / sonn / sonn quote
Last: | $0.85 |
---|---|
Change Percent: | -2.32% |
Open: | $0.880051 |
Close: | $0.85 |
High: | $0.880051 |
Low: | $0.85 |
Volume: | 30,233 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.85 | $0.880051 | $0.85 | $0.880051 | $0.85 | 30,233 | 07-19-2024 |
$0.8601 | $0.9 | $0.8601 | $0.9 | $0.85 | 22,476 | 07-18-2024 |
$0.9 | $0.8867 | $0.9 | $0.9 | $0.86 | 44,403 | 07-17-2024 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.855 | 66,184 | 07-16-2024 |
$0.89 | $0.86 | $0.89 | $0.9 | $0.85 | 56,231 | 07-15-2024 |
$0.871499 | $0.8808 | $0.871499 | $0.9 | $0.85 | 55,511 | 07-12-2024 |
$0.91 | $0.85 | $0.91 | $0.92 | $0.825 | 157,484 | 07-11-2024 |
$0.8401 | $0.9 | $0.8401 | $0.9 | $0.833 | 50,263 | 07-10-2024 |
$0.8799 | $0.88 | $0.8799 | $0.92 | $0.85 | 54,470 | 07-09-2024 |
$0.9 | $0.92 | $0.9 | $0.92 | $0.85 | 74,650 | 07-08-2024 |
$0.91 | $0.8857 | $0.91 | $0.9598 | $0.88 | 57,923 | 07-05-2024 |
$0.88 | $0.905 | $0.88 | $0.9101 | $0.88 | 8,949 | 07-04-2024 |
$0.88 | $0.905 | $0.88 | $0.9101 | $0.88 | 8,949 | 07-03-2024 |
$0.88 | $0.931 | $0.88 | $0.931 | $0.8711 | 68,186 | 07-02-2024 |
$0.93 | $0.9424 | $0.93 | $0.9424 | $0.92 | 7,000 | 07-01-2024 |
$0.9375 | $0.95 | $0.9375 | $0.959999 | $0.92 | 31,328 | 06-28-2024 |
$0.94845 | $0.92 | $0.94845 | $0.957 | $0.91 | 65,169 | 06-27-2024 |
$0.9319 | $0.92 | $0.9319 | $0.94 | $0.91 | 55,182 | 06-26-2024 |
$0.92 | $0.95 | $0.92 | $0.9504 | $0.8705 | 100,420 | 06-25-2024 |
$0.916 | $0.9787 | $0.916 | $0.997899 | $0.9 | 67,899 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sonnet BioTherapeutics Holdings Inc. Company Name:
SONN Stock Symbol:
NASDAQ Market:
Sonnet BioTherapeutics Holdings Inc. Website:
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.5% to $130.78 on volume of 504,910,586 shares Nikola Corporation (NKLA) fell 31.5% to $0.3296 on volume of 265,124,783 shares SMX (Security Matters) Public Limited Company (SMX) rose 35.1% to $0.1608 o...
PRINCETON, N.J., June 20, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing targeted immunotherapeutic drugs, announced today the entry into a definitive agreement for the immed...
Sonnet discovered and characterized a modified version of Interleukin-18 (IL-18 Binding Protein Resistant or IL-18 BPR ) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable binding to the inhibitory IL-18 Binding Protein (IL-18BP) ...